COVID-19人体挑战试验的伦理审查:HRA/WHO联合研讨会
本文报告世界卫生组织(WHO)与英国卫生研究管理局(HRA)联合研讨会内容,讨论在大流行期间开展的首批COVID-19人体挑战试验的伦理审查,评估WHO《COVID-19人体挑战试验伦理可接受性关键标准》作为审查实用资源的作用及英国HRA设立专门特设研究伦理委员会的做法,并汇总伦理委员会成员与研究者的反思。
要点
- WHO《关键标准》被视为国际共识文件,在设定规范和界定伦理可接受必要条件方面发挥重要作用。
- 研讨会成员建议《关键标准》可实际用于支持研究者和伦理审查者,包括培训伦理委员会成员。
- 报告还考虑COVID-19人体挑战试验与下一代疫苗及接种程序优化相关的潜在持续科学合理性。
核心结论
- 研讨会广泛认同WHO《关键标准》是国际共识文件,在设定规范和界定COVID-19人体挑战试验伦理可接受必要条件方面发挥强大作用。
- 研讨会成员建议WHO《关键标准》可实际实施以支持研究者和伦理审查者,包括用于伦理委员会成员培训。
- 未来可通过原始文件及潜在补充材料接触更广泛受众,补充材料可参考本文所述首批COVID-19人体挑战试验参与者的经验。
研究设计与样本
- 本文为WHO与英国HRA联合研讨会的报告,讨论首批COVID-19人体挑战试验的伦理审查。
- 报告回顾国际与 national 机构为界定COVID-19人体挑战试验伦理标准及建立严格及时审查框架的早期努力。
- 报告评估WHO《COVID-19人体挑战试验伦理可接受性关键标准》作为伦理审查实用资源的作用。
- 报告评估英国HRA对复杂伦理审查的做法,包括成立COVID-19人体挑战试验专门特设研究伦理委员会(REC)审查所有当前和未来此类研究。
- 报告概述REC成员与研究者对首批COVID-19人体挑战试验伦理审查过程的反思,并考虑其潜在持续科学合理性。
主要发现
- 研讨会广泛认同WHO《关键标准》是国际共识文件,在设定规范和界定伦理可接受必要条件方面发挥强大作用。
- 研讨会成员建议WHO《关键标准》可实际实施以支持研究者和伦理审查者,包括培训伦理委员会成员。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
This report of a joint World Health Organization (WHO) and United Kingdom (UK) Health Research Authority (HRA) workshop discusses the ethics review of the first COVID-19 human challenge studies, undertaken in the midst of the pandemic. It reviews the early efforts of international and national institutions to define the ethical standards required for COVID-19 human challenge studies and create the frameworks to ensure rigorous and timely review of these studies. This report evaluates the utility of the WHO's international guidance document Key criteria for the ethical acceptability of COVID-19 human challenge studies (WHO Key Criteria) as a practical resource for the ethics review of COVID-19 human challenge studies. It also assesses the UK HRA's approach to these complex ethics reviews, including the formation of a Specialist Ad-Hoc Research Ethics Committee (REC) for COVID-19 Human Challenge Studies to review all current and future COVID-19 human challenge studies. In addition, the report outlines the reflections of REC members and researchers regarding the ethics review process of the first COVID-19 human challenge studies. Finally, it considers the potential ongoing scientific justification for COVID-19 human challenge studies, particularly in relation to next-generation vaccines and optimisation of vaccination schedules. Overall, there was broad agreement that the WHO Key Criteria represented an international consensus document that played a powerful role in setting norms and delineating the necessary conditions for the ethical acceptability of COVID-19 human challenge studies. Workshop members suggested that the WHO Key Criteria could be practically implemented to support researchers and ethics reviewers, including in the training of ethics committee members. In future, a wider audience may be engaged by the original document and potential additional materials, informed by the experiences of those involved in the first COVID-19 human challenge studies outlined in this document.
引用
- Williams E, Craig K, Chiu C, et al. Ethics review of COVID-19 human challenge studies: A joint HRA/WHO workshop. Vaccine. 2022. PMID: 35210119. doi:10.1016/j.vaccine.2022.02.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。